BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9362165)

  • 1. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Duffy MJ; Duggan C
    J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
    [No Abstract]   [Full Text] [Related]  

  • 3. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    See WA
    J Natl Cancer Inst; 1998 Sep; 90(17):1303. PubMed ID: 9731738
    [No Abstract]   [Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator and its receptor in bladder cancer.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
    [No Abstract]   [Full Text] [Related]  

  • 6. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation by receptor-bound urokinase.
    Ellis V; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
    [No Abstract]   [Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
    Blasi F; Vassalli JD; Danø K
    J Cell Biol; 1987 Apr; 104(4):801-4. PubMed ID: 3031083
    [No Abstract]   [Full Text] [Related]  

  • 9. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
    Behrendt N; Danø K
    FEBS Lett; 1997 Feb; 402(2-3):293-4. PubMed ID: 9037213
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
    Higazi AA
    FEBS Lett; 1997 Feb; 402(2-3):291-2. PubMed ID: 9037212
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
    Ossowski L; Clunie G; Masucci MT; Blasi F
    J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
    Hollas W; Boyd D
    Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator.
    Fibbi G; Magnelli L; Pucci M; Del Rosso M
    Exp Cell Res; 1990 Mar; 187(1):33-8. PubMed ID: 2153567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine saturation of pro-urokinase receptors on human A431 cells.
    Stoppelli MP; Tacchetti C; Cubellis MV; Corti A; Hearing VJ; Cassani G; Appella E; Blasi F
    Cell; 1986 Jun; 45(5):675-84. PubMed ID: 3011276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
    Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic urokinase binding sites on human foreskin fibroblasts.
    Bajpai A; Baker JB
    Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Cancer Res; 1995 Jan; 55(1):90-5. PubMed ID: 7805047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.